Office Visits Before Screening Colonoscopy Raise Costs

Share this content:
Office Visits Before Screening Colonoscopy Raise Costs
Office Visits Before Screening Colonoscopy Raise Costs

WEDNESDAY, Feb. 3, 2016 (HealthDay News) -- Despite the availability of open-access colonoscopy in the United States, about one-third of colonoscopies for colon cancer screening and polyp surveillance are preceded by a visit to a gastroenterology office, according to a research letter published in the Feb. 2 issue of the Journal of the American Medical Association.

Kevin R. Riggs, M.D., M.P.H., of Johns Hopkins University in Baltimore, and colleagues analyzed billing data for individuals, aged 50 to 64 years, with employer-sponsored private health insurance from 2010 through 2013. The authors sought to examine the proportion of colonoscopies for colon cancer screening and polyp surveillance that were preceded by office visits and the payments associated with these visits.

The researchers found that 247,542 (29.4 percent) of 842,849 patients who underwent a colonoscopy had an office visit prior to the procedure. Patients who had preceding office visits had a higher Charlson Comorbidity Index and were more likely to reside in the South. Most office visits (77.4 percent) were associated with a diagnosis of either screening or preoperative evaluation. The payment for office visits averaged $123.83. Distributed across all patients, the added cost of precolonoscopy visits averaged $36.37 per colonoscopy.

"Identifying which patients benefit from a precolonoscopy office visit and targeting those patients could increase the value of colon cancer screening," the authors write.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »